Lantern Pharma Balance Sheet
Lantern Pharma's total assets for Q4 2025 were $11.04B, an increase of 80886.02% from the previous quarter. LTRN total liabilities were $4.50B for the fiscal quarter, a 111326.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.